The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

The global tinea pedis treatment market is on a robust growth trajectory, projected to reach a market value of USD 2,484 ...

The Capital Structure page of GlaxoSmithKline Pharmaceuticals Ltd. presents the Authorized Capital, Issued Capital, and Paid-Up Equity Capital of the company over the period.

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

The company’s technology, which enables it to target viral proteins in their “prefusion” shape and skip a manufacturing step, could lead to vaccines that are more potent and easier to produce, said ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

The former head of vaccine R&D at GSK has pulled together $100 million for a London-based biotech working on respiratory ...

Global Necrotizing Fasciitis Market is valued at approximately USD 260.03 million in 2023 and is anticipated to grow at a robust compound annual growth rate (CAGR) of 6.88% over the forecast period ...

The stories of fallen IDF soldiers Yosef Malachi Guedalia, Dekel Suisa, and Aviad and Erez Deri – and those who mourned them at Mount Herzl military cemetery, months and years later. The police ...

Allison Freedman is opening up about her fight with multiple myeloma during Blood Cancer Awareness Month. She went from being ...

World leaders and business executives are flocking to New York City to make a case for bold efforts to expand clean energy and enhance climate aid for imperiled countries. Hanging over them all is ...

Tinnitus Management Market is projected to grow at a CAGR of 3.7%, reaching an impressive USD 3.7 billion by 2033.